Lægemidler, som inducerer CYP3A4, CYP2C9 eller CYP2C19, kan øge clearance af etravirin, hvilket kan reducere plasmakoncentrationen af etravirin.
Medicinal products that induce CYP3A4, CYP2C9 or CYP2C19 may increase the clearance of etravirine, resulting in lowered plasma concentrations of etravirine.